連詩雅擔任BOTOX®及Juvéderm®全新品牌代言人！ 見證1億個美麗時刻，綻放自信美！

剛榮升幸福人妻的Shiga連詩雅即使出道多年，近看膚質仍像妙齡少女般白滑細嫩，飽滿立體的蘋果肌和緊緻輪廓更讓人羨慕不已。Shiga近日更正式擔任 BOTOX®及Juvéderm®全新品牌代言人，鼓勵大家不再讓年齡限制對美的想像，選擇值得信賴的好幫手，綻放自信魅力。

平日靠化妝品能勉強遮蓋暗瘡印、黑眼圈等臉部瑕疵，但開懷大笑時浮現的魚尾紋、生氣時鼓起的眉心紋卻怎樣也遮蓋不住！想徹底消除表情紋，BOTOX®便是你的信心之選。BOTOX®是唯一美國FDA認證能擺脫額頭紋、眉心紋及魚尾紋3大顯老表情紋的醫美療程²，簡單10分鐘的療程便能放鬆導致表情紋的肌肉並撫平皺紋³，效果持效達6個月¹，讓大家從此無懼表情紋，盡情展露自信笑容，放膽表達真我個性。

很多女生都自以為還年輕不需要「抗衰老」，但其實25歲後皮膚彈性便開始無止境下降，骨質及脂肪流失移位更令輪廓結構產生變化，造成淚溝、虎紋、蘋果肌鬆弛下垂等初老徵狀⁷。近年越來越多人選擇接受長效透明質酸療程，達致提昇飽滿的拉提效果⁴。全球No.1長效透明質酸品牌ǂ Juvéderm®長效透明質酸以國際專利技術VYCROSSTM製造⁸，其高融合度能與肌膚完美融為一體，效果長效自然⁹⁻¹⁰。不同濃度及承托力的長效透明質酸產品能針對用家面部的各種需要，從根本著手解決鬆弛下垂、虎紋、淚溝及缺水暗沉等問題^4,5,11,12，滿足各種變美願望，效果長達2年¹³，讓大家自信展現360度零死角美貌！

References:

§Medical Insight, Inc 2018. Global Facial Injectables Market Study. December 2018. Based on worldwide neurotoxins market 2017 (in sales value). ‡Allergan. Data on File. REF-74203. Juvéderm®, the world’s leading brand of hyaluronic acid facial fillers INT/0771/2016(2). Feb 2019. Based on HCP tracking market research, from over 1000 HCPs in the largest 13 aesthetic markets worldwide.^ Allergan. Unpublished Data. INT/0771/2016(2). JUVÉDERM®️, the world’s leading brand of hyaluronic acid facial fillers. Feb 2019.† Allergan. Data on File. REF-96563. FILLERS GLOBAL NUMBER OF SYRINGES. 100 million Juvéderm® syringes manufactured worldwide from 2004 to April 2022. May 2022. # BOTOX® Prescribing Information. HK-41906. May 2013.1: De Boulle K, et al. Dermatol Surg. 2018;44(11):1437–48. 2: U.S. Food and Drug Administration, Department of Health & Human Services. Botox approval letter SUPPL-5303, October 2, 2017. 3: Tremaine AM, McCullough JL. Clin Cosmet Investig Dermatol. 2010;3:15–23. 4: De Maio M, et al. Plast Reconstr Surg. 2017 Oct;140(4):540e-550e. 5: Ogilvie P et al. J Cosmetic Dermatol. 2019;00:1-6. 6: VOLUX™, VOLUMA®, VOLIFT® 及 VOLBELLA® (approval as VOLUX™ XC, VOLUMA® XC, VOLLURE® XC and VOLBELLA® XC in US)  均獲得美國 FDA 認證. U.S. Food and Drug Administration, Department of Health & Human Services. Juvéderm VOLUX XC approval letter P110033/S065, July 2022; Juvéderm VOLUMA XC approval letter P110033/S047, Jun 2020; Juvéderm VOLLURE XC approval letter P110033/S020, Mar 2017; Juvéderm VOLBELLA XC approval letter P110033/S053, May 2021. 7: Swift A et al. Aesthet Surg J. 2021 Sep 14;41(10):1107-1119. 8: Goodman GJ et al. Plast Reconstr Surg. 2015;136(5 Suppl):139–48. 9: Allergan. Unpublished Data. INT-JUV-1950127. VYCROSS® – longest duration of hyaluronic acid facial filler in clinical trials. Jan 2020. Based on a search of published clinical studies of hyaluronic acid facial fillers in November 2019. A duration of 24 months was established in Juvéderm® VOLUMA with lidocaine, depending on the treatment area chosen.10: Hee CK et al. Dermatol Surg. 2015;41(Suppl 1):S373–81.11: De Maio M, et al. Plast Reconstr Surg. 2017 Aug;140(2):265e-276e. 12: De Maio M. et. al. Plast Reconstr Surg. 2017 Sep;140(3):393e-404e. 13: Callan P, et al. Clin Cosmet Investig Dermatol. 2013;6:81-9.

BOTOX®保妥適® (Botulinum Toxin Type A) 藥品註冊編號: HK-41906. Juvéderm® (Hyaluronic Acid Gel with Lidocaine) 產品系列包括VOLUX™ (HKMD-190341), VOLUMA® (HKMD-100411), VOLIFT® (HKMD-130324), VOLBELLA® (HKMD-210451) 及VOLITE™ (HKMD-180040)。療程效果因人而異。療程後如有任何不良反應，請即向醫生查詢 。All adverse events should be reported to drugsafety.pv@abbvie.com. Allergan Aesthetics, an AbbVie company. Suite 2404-08, 24/F, AIA Tower, 183 Electric Road, North Point, Hong Kong. Tel: (852) 2610 2525. HK-JUV-230030 | 28/Apr/23

資料由客戶提供。